Stavudine

Generic Name: Stavudine

Brand Names: Zerit

Drug Type: Small Molecule

Chemical Formula: C_₁₀H_₁₂N_₂O_₄

CAS Number: 3056-17-5

Unique Ingredient Identifier: BO9LE4QFZF

Background: A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.

Indication: For the treatment of human immunovirus (HIV) infections.

Associated Conditions: Human Immunodeficiency Virus (HIV) Infections

Associated Therapies: -

Clinical Trials

Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Pharmacia and Upjohn

Target Recruit Count: 160

Registration Number: NCT00002211

Locations: 🇺🇸
Pharmacia & Upjohn, Peapack, New Jersey, United States

A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Phase 3

Completed

Conditions: HIV Infections
AIDS-Associated Nephropathy

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Hoffmann-La Roche

Target Recruit Count: 24

Registration Number: NCT00002397

Locations: 🇺🇸
Mount Sinai Med Ctr, New York, New York, United States

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Phase 3

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: PPD

Target Recruit Count: 200

Registration Number: NCT00006397

Locations: 🇺🇸
East Bay AIDS Ctr, Berkeley, California, United States
🇺🇸
JSI Research and Training Institute, Boston, Massachusetts, United States
🇺🇸
Univ of Texas Southwestern Med Ctr, Dallas, Texas, United States

and more 12 locations

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Phase 2

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 8

Registration Number: NCT00002451

Locations: 🇺🇸
Albany Med College, Albany, New York, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
SUNY at Stony Brook / Division of Infectious Diseases, Stony Brook, New York, United States

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 540

Registration Number: NCT00002354

Locations: 🇺🇸
Merck & Co Inc, Whitehouse Station, New Jersey, United States

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Hoffmann-La Roche

Target Recruit Count: 825

Registration Number: NCT00002378

Locations: 🇺🇸
Northwestern Univ Med Ctr, Chicago, Illinois, United States
🇺🇸
Lehigh Valley Hosp, Allentown, Pennsylvania, United States
🇺🇸
North Texas Infectious Disease Consultants, Dallas, Texas, United States

and more 98 locations

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2012-06-07

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 900

Registration Number: NCT00000919

Locations: 🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
🇺🇸
Marin County Specialty Clinic, San Rafael, California, United States
🇺🇸
Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr, Atlanta, Georgia, United States

and more 77 locations

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2009-02-20

Lead Sponsor: Abbott

Target Recruit Count: 660

Registration Number: NCT00004583

Locations: 🇺🇸
Vanderbilt Univ Med Ctr, Nashville, Tennessee, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Tower ID Med Associates, Los Angeles, California, United States

and more 80 locations

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Phase 3

Suspended

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Triangle Pharmaceuticals

Registration Number: NCT00002362

Locations: 🇺🇸
Northstar Med Clinic, Chicago, Illinois, United States
🇺🇸
Houston Clinical Research Network, Houston, Texas, United States
🇺🇸
Univ of Texas / Med School at Houston, Houston, Texas, United States

and more 7 locations

A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Hoffmann-La Roche

Target Recruit Count: 120

Registration Number: NCT00002374

Locations: 🇺🇸
Ctr for Quality Care, Tampa, Florida, United States
🇺🇸
AIDS Ctr, New York, New York, United States
🇺🇸
Pacific Oaks Med Ctr, Beverly Hills, California, United States

and more 4 locations

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy